Houlihan Lokey (HLI) Upgraded to “Buy” at Zacks Investment Research
Houlihan Lokey (NYSE:HLI) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Friday. The firm presently has a $56.00 price objective on the financial services provider’s stock. Zacks Investment Research‘s target price would indicate a potential upside of 11.44% from the stock’s current price.
According to Zacks, “Houlihan Lokey, Inc. is an investment bank which focuses on mergers and acquisitions, financings, financial restructurings and financial advisory services. The Company’s operating segments consist of Corporate Finance, encompassing M&A and capital markets advisory; Financial Restructuring both out-of-court and in formal bankruptcy or insolvency proceedings; Financial Advisory Services, including financial opinions and a variety of valuation services; and Strategic Consulting, which advises in the areas of strategy development, operations, and performance improvement. It operates primarily in the United States, Europe, Asia and Australia. Houlihan Lokey, Inc. is headquartered in LOS ANGELES, United States. “
A number of other equities analysts have also commented on the stock. Keefe, Bruyette & Woods reissued a “buy” rating and issued a $52.00 price target on shares of Houlihan Lokey in a research report on Thursday. Bank of America lifted their price target on shares of Houlihan Lokey from $40.00 to $44.00 and gave the company a “neutral” rating in a research report on Wednesday, October 25th. UBS Group lifted their price target on shares of Houlihan Lokey from $44.00 to $47.00 and gave the company a “buy” rating in a research report on Wednesday, October 25th. Finally, ValuEngine raised shares of Houlihan Lokey from a “hold” rating to a “buy” rating in a research report on Friday, September 15th. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $46.17.
Houlihan Lokey (NYSE:HLI) last released its quarterly earnings results on Tuesday, October 24th. The financial services provider reported $0.56 EPS for the quarter, beating the Zacks’ consensus estimate of $0.41 by $0.15. Houlihan Lokey had a net margin of 14.58% and a return on equity of 19.71%. The company had revenue of $242.20 million for the quarter, compared to analyst estimates of $207.72 million. During the same quarter last year, the firm posted $0.37 earnings per share. The company’s quarterly revenue was up 29.9% compared to the same quarter last year. research analysts expect that Houlihan Lokey will post 2.1 EPS for the current fiscal year.
In other news, General Counsel Christopher M. Crain sold 4,014 shares of the firm’s stock in a transaction on Monday, October 30th. The shares were sold at an average price of $41.63, for a total value of $167,102.82. Following the sale, the general counsel now owns 6,063 shares in the company, valued at $252,402.69. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider J Lindsey Alley sold 973 shares of the firm’s stock in a transaction on Friday, November 3rd. The stock was sold at an average price of $41.63, for a total transaction of $40,505.99. Following the completion of the sale, the insider now owns 973 shares in the company, valued at approximately $40,505.99. The disclosure for this sale can be found here. In the last 90 days, insiders sold 2,120,627 shares of company stock worth $88,281,702. 69.70% of the stock is currently owned by corporate insiders.
Several institutional investors have recently made changes to their positions in HLI. Schwab Charles Investment Management Inc. grew its stake in shares of Houlihan Lokey by 133.3% in the second quarter. Schwab Charles Investment Management Inc. now owns 46,900 shares of the financial services provider’s stock worth $1,637,000 after acquiring an additional 26,800 shares during the last quarter. Rhumbline Advisers grew its stake in shares of Houlihan Lokey by 100.4% in the second quarter. Rhumbline Advisers now owns 25,109 shares of the financial services provider’s stock worth $876,000 after acquiring an additional 12,581 shares during the last quarter. SG Americas Securities LLC acquired a new stake in shares of Houlihan Lokey in the second quarter worth $105,000. Bank of New York Mellon Corp grew its stake in shares of Houlihan Lokey by 3.2% in the second quarter. Bank of New York Mellon Corp now owns 137,759 shares of the financial services provider’s stock worth $4,808,000 after acquiring an additional 4,238 shares during the last quarter. Finally, Legal & General Group Plc grew its stake in shares of Houlihan Lokey by 12.3% in the second quarter. Legal & General Group Plc now owns 5,198 shares of the financial services provider’s stock worth $182,000 after acquiring an additional 570 shares during the last quarter. Institutional investors and hedge funds own 34.61% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Houlihan Lokey (HLI) Upgraded to “Buy” at Zacks Investment Research” was originally published by American Banking News and is owned by of American Banking News. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at https://www.americanbankingnews.com/2018/01/12/houlihan-lokey-hli-upgraded-to-buy-at-zacks-investment-research.html.
Houlihan Lokey Company Profile
Houlihan Lokey, Inc is a global independent investment bank that focuses on mergers and acquisitions (M&A), capital markets, financial restructuring, valuation, and strategic consulting. The Company operates through four segments: Corporate Finance, Financial Restructuring, Financial Advisory Services and Strategic Consulting.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Houlihan Lokey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Houlihan Lokey and related companies with MarketBeat.com's FREE daily email newsletter.